MyHealthChecked PLC At-home wellness tests to launch on Amazon (6462T)
26 Julho 2022 - 3:00AM
UK Regulatory
TIDMMHC
RNS Number : 6462T
MyHealthChecked PLC
26 July 2022
MyHealthChecked PLC
( " MyHealthChecked " or the "Company " )
At-home wellness tests to launch on Amazon
MyHealthChecked Plc (AIM: MHC), the consumer home-testing
healthcare company, announces that its suite of cheek- swab DNA
at-home wellness tests will be available from today to purchase
through the UK site of online retailer, Amazon.com, Inc. (NASDAQ:
AMZN) ("Amazon").
The tests were initially launched by MyHealthChecked and
available for purchase on the Company's website on 14 June 2022 .
Customers will now be able to purchase four tests directly via
Amazon UK, with the launch of the Glucose Management DNA test
expected to follow. The tests will be priced at GBP54 per test, and
will be delivered to users by Royal Mail Tracked 24.
The tests that will be available in MyHealthChecked's at-home
wellness range and launching on Amazon are:
Intolerances & Sensitivities to identify genetic variants associated with intolerances,
such as gluten and lactose, as well as sensitivities,
including caffeine, salt and alcohol
Weight Management intended for use by those wishing to identify their
genetic susceptibility to becoming overweight and
their responsiveness to weight loss interventions
at a molecular and metabolic level, including genetic
interactions
Heart Profile identifying how individuals respond differently
to diet. This will facilitate optimisation of heart
health parameters by using personalised dietary
advice
Vitamins & Minerals this test indicates the predisposition towards
a nutrient deficiency or toxicity, to highlight
nutrients or supplements an individual should increase
or deprioritise
MyHealthChecked's range of at-home wellness tests allow
individuals to make more informed choices about their health and
well-being from personalised, accurate results and advice.
Understanding genetic disposition provides individuals with the
power to be proactive about their health and well-being through
lifestyle and diet management, allowing individuals to fully unlock
their health potential.
The launch of the tests via Amazon supports the Company's
strategy of accessible healthcare for all, enabling the Company to
broaden its reach, as the demand for health and wellness tests
expands. All tests will continue to be available via the
MyHealthChecked website ( www.myhealthchecked.com/wellness ), also
priced at GBP54 per test, which also provides access to information
about the benefits of DNA use, details of the Scientific Advisory
team and full customer facts and questions.
Penny McCormick, Chief Executive Officer of MyHealthChecked Plc
, said: "We are excited to be launching our wellness tests with
Amazon and believe this will greatly increase the accessibility of
our product range. Following the success of our partnership with
the UK's top high street pharmacy retailers for our COVID testing
service, we have seen the real value that additional retail
partners can bring to the business by broadening our customer base
and significantly increasing our market share."
For further information contact:
MyHealthChecked plc www.myhealthchecked.com
P enny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Oberon Capital Ltd (Broker) Tel: +44 (0)20 3179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44(0)
7407 804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests that have been developed following the acquisition of
The Genome Store in November 2020. The tests are available online,
and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCUVRURUWUBUAR
(END) Dow Jones Newswires
July 26, 2022 02:00 ET (06:00 GMT)
MyHealthChecked (AQSE:MHC.GB)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
MyHealthChecked (AQSE:MHC.GB)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
